Moderna & Merck study: mRNA therapy plus KEYTRUDA cut melanoma recurrence risk by half
The study evaluated patients with stage III/IV melanoma after complete tumor resection
The study evaluated patients with stage III/IV melanoma after complete tumor resection
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The opening of our 1000th pharmacy in Karnataka marks an important step
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
The center will offer training to super-specialist doctors and healthcare professionals in various fields
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
The non-dilutive financing includes three tranches
Subscribe To Our Newsletter & Stay Updated